Aniridia is an uncommon congenital bilateral disease that involves the cornea, anterior chamber, lens, retina and optic nerve. Corneal changes in aniridic keratopathy include recurrent erosions of corneal epithelium, tear film instability, chronic pain, corneal vascularisation, dry eye, progressive corneal opacification and blindness. The autologous serum contains a variety of growth factors, vitamins and immunoglobulins, some of which are in higher concentrations than in natural tears. The growth factors and protein found in the serum may help the proliferation, migration and adhesion of epithelial corneal cells. They are by nature non-allergenic and their biochemical and biomechanical properties are similar to those of normal tears. The ocular surface, including corneal impression cytology and tear film evaluation, of patients with congenital aniridia was studied prior to and after treatment with autologous serum eye drops.
Aniridia is an uncommon congenital bilateral disease caused by mutation of the PAX6 gene. It is an ocular disorder that involves the cornea, anterior chamber, lens, retina and optic nerve. 1 Although aniridic keratopathy has traditionally been attributed to limbal stem cell deficiency, current evidence based on clinical observations and animal models of aniridia suggests that the proliferative potential of limbal stem cells may not initially be affected and this corneal alteration may be related to an abnormality in the limbal stem cell microenvironment. 2 Corneal changes in aniridic keratopathy include recurrent erosions and ulcerations of corneal epithelium, tear film instability, dry eye, chronic pain, corneal vascularisation, progressive corneal opacification and blindness. 3 Tears perform a vital role in maintaining the health of the corneal epithelium. They contain substances such as epidermal growth factor (EGF), fibronectin, basic fibroblast growth factor (bFGF), vitamin A and other neural growth factors that are thought to maintain epithelial health; however, in dry eye the lack of tear production results in the deprivation of these epitheliotrophic factors. Tear film disorder and dry-eye syndrome have been reported in connection with congenital aniridia. 4, 5 Serum is the fluid of blood devoid of its cellular components and clotting factors. It contains a variety of growth factors, vitamins and immunoglobulins, some of which are in higher concentrations than in natural tears. Autologous serum eye drops have been reported previously for the treatment of ocular surface diseases. 6 Autologous serum provides epitheliotrophic factors such as EGF, bFGF, vitamin A, fibronectin, α2 macroglobulin and neural growth factors that facilitate the proliferation, migration and adhesion of epithelial corneal cells. By nature they are non-allergenic and their biochemical and biomechanical properties are similar to those of normal tears. Autologous serum facilitates mucin expression, which may contribute to the beneficial effects over the ocular surface in patients with dry eye. 7 We think that the epitheliotrophic factors present in autologous serum can help to treat the corneal changes that occur in patients with aniridia by a stem cell microenvironment improvement. With this purpose, a prospective study of 26 eyes from 13 patients (seven males and six females) with aniridic keratopathy before and after two months of autologous serum eye drops treatment was performed. Anterior Segment
between grades 0 and 5. classification) (see Figure 1A ). Group B comprised eight eyes with discontinuous areas of periphery vascular pannus (stage 1A) (see Figure 1B ). Group C had seven eyes with vascular pannus that involved the total peripheral cornea and extended centrally but did not affect the central area of the cornea (stage 1B) (see Figure 1C ).
Finally, group D comprised six eyes with central corneal involvement by neovascular pannus and stromal opacity (stage 2) (see Figure 1D ).
Only patients treated with preservative-free artificial tears in the previous three months were included in the study. Slitlamp exploration and ocular surface photography were used to evaluate the corneal surface and tear film before treatment and every two or three days until serum drops were stopped. An independent physician examined these photographs. Impression cytology was made prior to starting the serum eye drop treatment and until a few days after treatment ended. Tear film production and stability were evaluated by the same physician (JSLG) two times during the study: prior to starting the serum eye drops and a few days after treatment ended. We think that this improvement is due to the beneficial effects of 
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autologous serum over the epithelial surface that diminished the inflammation and stimulation of the blood vessels.
Dry-eye severity was correlated with the keratopathy grade. In these patients, the aqueous layer produced by lacrimal glands did not change, as demonstrated by the normal Shirmer's test in all patients except the most severe eyes. By contrast, BUT was altered in practically all patients. This test measures tear stability, but it is a non-specific test that is altered in all dry-eye types. Autologous serum eye drop treatment significantly improved Schirmer and BUT levels in all patients. After the treatment, only eyes with severe keratopathy showed pathological levels in BUT and Schirmer's test.
The autologous serum effect was more important in the BUT cohort because these levels were pathologically diminished in all eyes except group A. We think that the autologous serum effects on mucin expression, meibomian dysfunction and epithelial surface improved tear stability and BUT levels. The fluorescein stain also showed better tear stability and an increase in tear meniscus level after treatment with autologous serum (see Figure 2 ). Fluorescein and rose bengal staining patterns of the cornea improved after treatment.
The corneal epithelial cell squamous metaplasia obtained by impression cytology analysis correlated with keratopathy severity.
Metaplasia was present in all patients in this study; even the group A eyes, without keratopathy symptoms, showed a grade 2 squamous 
Conclusion
Autologous serum has biochemical and biomechanical properties similar to those of normal tears, is non-allergenic and has antimicrobial and optic properties. It contains epitheliotrophic factors that are thought to be responsible for the therapeutic effect over ocular surface disorders. In this work, we found that the autologous serum eye drops improved aniridic keratopathy in all patients, but especially in patients with slight or moderate severity. In these patients, autologous serum eye drops were superior to conventional therapy with substitute tears in terms of improving ocular surface and subjective comfort. 
